Yet, we show here that 5-FU or cisplatin chemotherapy enrich for CD133/Prom1, suggesting that while CD133 may be proliferative, they may also harbor other mechanisms (e.g., SPINK1-mediated tumor plasticity) that enable them to resist standard chemotherapy. Here, PROM1 is linked to neoplasm.